H.R. 3537 — Reported in House

IB Union Calendar No. 615 114th CONGRESS 2d Session H. R. 3537 [Report No. 114–787, Part I] IN THE HOUSE OF REPRESENTATIVES September 17, 2015 Mr. Dent (for himself, Mr. Himes, Mr. Meehan, Mr. Dold, Mr. Tiberi, Mr. Costello of Pennsylvania, Mr. Hanna, Mr. Thompson of Pennsylvania, Mr. Rogers of Kentucky, Mr. Murphy of Pennsylvania, Mr. Barletta, Ms. Norton, Mr. Lance, Mrs. Comstock, Mr. Katko, Ms. Ros-Lehtinen, and Mr. Jolly) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned September 26, 2016Additional sponsors: Mr. Rodney Davis of Illinois, Mr. Cuellar, Mr. Guthrie, Mr. Thornberry, Mr. Bishop of Michigan, Mr. King of New York, Mr. Allen, Mr. Pierluisi, Ms. Kaptur, Mr. Peters, and Ms. Velázquez September 26, 2016 Reported from the Committee on Energy and Commerce with amendments Strike out all after the enacting clause and insert the part printed in italic September 26, 2016The Committee on the Judiciary discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printedFor text of introduced bill, see copy of bill as introduced on September 17, 2015 A BILL To amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, and for other purposes. 1. Short title This Act may be cited as the Dangerous Synthetic Drug Control Act of 2016. 2. Treatment of certain designer drugs as schedule I controlled substances (a) Cannabimimetic agents Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)— (1) in clause (xiv) by striking and at the end; (2) in clause (xv) by striking the period and inserting a semicolon; and (3) by adding at the end the following: (xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251); (xvii) (1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073); (xviii) 2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302); (xix) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA); (xx) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22); (xxi) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA); (xxii) N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24); (xxiii) (1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201); (xxiv) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA); (xxv) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and (xxvi) methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MA–CHMINACA). . (b) Synthetic opioids Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following: (43) Butyryl fentanyl. (44) beta-Hydroxythiofentanyl. (45) Acetyl fentanyl. . (c) Other drugs Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following: (29) 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone). (30) 1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB). (31) 1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB). (32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI). (33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI). (34) 1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly). (35) 1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC). (36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM). . Amend the title so as to read: A bill to amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes.. September 26, 2016 Reported from the Committee on Energy and Commerce with amendmentsSeptember 26, 2016The Committee on the Judiciary discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed